Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

This bill focuses on uterine fibroids—common, noncancerous growths that can cause heavy bleeding, pain, and other health problems. It directs the federal health agency to boost research, track care in Medicaid and CHIP, and share clear information with the public and doctors. The bill notes that fibroids affect many people (20–50% of women of reproductive age now; up to 77% by menopause) and often hit people of color harder, with more severe symptoms and earlier onset. It also highlights the high costs to families and the country, and the need for better, less invasive treatments and better evidence on what works .

Key actions include: $30 million a year for research (2026–2030); a national database to study what fibroid care Medicaid and CHIP patients receive, plus a spending report to Congress within two years of enactment; a public education campaign covering risks and treatment options, including non-hysterectomy choices; and guidance to doctors to support evidence-based, patient-centered care, including options other than hysterectomy. Education and provider efforts are authorized for funding as needed from 2026–2030 .

• Who is affected: People with uterine fibroids, especially those in minority groups who face higher risks and more severe symptoms; Medicaid and CHIP patients will be part of the data review; health care providers will receive updated guidance .